Detalles de la búsqueda
1.
21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology.
Breast Cancer Res Treat
; 168(1): 69-77, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29128898
2.
Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In Situ.
Ann Surg Oncol
; 24(3): 660-668, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27704370
3.
Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial.
J Surg Oncol
; 115(8): 917-923, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28407247
4.
A phase II trial of ixabepilone and cyclophosphamide as neoadjuvant therapy for patients with HER2-negative breast cancer: correlation of pathologic complete response with the 21-gene recurrence score.
Breast Cancer Res Treat
; 154(2): 299-308, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26507191
5.
The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: A prospective clinical utility assessment of the 12-gene DCIS score™ result.
J Surg Oncol
; 111(8): 935-40, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26031501
6.
Erratum: Re: Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial. Journal of Surgical Oncology 2017;115(8):917-923.
J Surg Oncol
; 118(4): 722, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30295942
7.
Exploring racial differences in outcome and treatment for metastatic colorectal cancer: results from a large prospective observational cohort study (BRiTE).
Cancer
; 118(4): 1083-90, 2012 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21800287
8.
Bevacizumab treatment to progression after chemotherapy: outcomes from a U.S. community practice network.
Oncologist
; 16(4): 486-96, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21441299
9.
Clinical outcomes in elderly patients with metastatic colorectal cancer receiving bevacizumab and chemotherapy: results from the BRiTE observational cohort study.
Oncology
; 78(5-6): 329-39, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20733336
10.
21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy.
J Natl Cancer Inst
; 109(4)2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28122895
11.
Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.
J Clin Oncol
; 23(4): 792-9, 2005 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15681523
12.
Prognostic Impact of the Combination of Recurrence Score and Quantitative Estrogen Receptor Expression (ESR1) on Predicting Late Distant Recurrence Risk in Estrogen Receptor-Positive Breast Cancer After 5 Years of Tamoxifen: Results From NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-28 and B-14.
J Clin Oncol
; 34(20): 2350-8, 2016 07 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27217450
13.
Use of Gene Expression Profiling and Chemotherapy in Early-Stage Breast Cancer: A Study of Linked Electronic Medical Records, Cancer Registry Data, and Genomic Data Across Two Health Care Systems.
J Oncol Pract
; 12(6): e697-709, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27221993
14.
Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013.
J Clin Oncol
; 34(20): 2359-65, 2016 07 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27001590
15.
A phase I trial of the single-chain immunotoxin SGN-10 (BR96 sFv-PE40) in patients with advanced solid tumors.
Clin Cancer Res
; 8(10): 3092-9, 2002 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12374676
16.
Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by Age.
Adv Ther
; 32(12): 1222-36, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26610382
17.
A Prospective Comparison of the 21-Gene Recurrence Score and the PAM50-Based Prosigna in Estrogen Receptor-Positive Early-Stage Breast Cancer.
Adv Ther
; 32(12): 1237-47, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26610383
18.
A retrospective study of the impact of 21-gene recurrence score assay on treatment choice in node positive micrometastatic breast cancer.
Pharmaceuticals (Basel)
; 8(1): 107-22, 2015 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-25789420
19.
Gastrointestinal perforation associated with bevacizumab use in metastatic colorectal cancer: results from a large treatment observational cohort study.
Eur J Cancer
; 48(8): 1126-32, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22424880
Resultados
1 -
19
de 19
1
Próxima >
>>